Nigeria to export cashew nuts by 2019

The Minister of Agriculture and Rural Development, Mr Audu Ogbeh, on Tuesday, said that the country would start processing its raw cashew nuts for export by 2019.
Ogbeh made this known at the maiden edition of the 2017 First Bank Agric Expo in Lagos.
The expo is tagged: Reinventing Agriculture for Sustainable National Development.
According to him, the current worth of a tonne of roasted or processed cashew nut for export is $10,000 while the raw cashew nut is sold for $1,200.
He said it would be better to process the nuts for export instead of exporting raw cashew nuts in order to benefit from the high cost of cashew nuts.
“So in the next two years we will no longer export raw cashew nuts, but roast the cashew nuts for export.
“If we produce a tonne of roasted cashew it will be sold at the international price of $10,000, whereas a tonne of raw cashew nuts sells for $1,200.”
Ogbeh also said that Nigeria shipped a total of $600,000 worth of raw cashew nuts to Vietnam alone in 2016.
(NAN)
ABEOKUTA-The President of Pentecostal Sanctuary Bible Ministries Worldwide, Prophet Sunday Iyunade has predicted a possible end to the reign of democracy in Nigeria after the administration of Muha

Read more at: http://www.vanguardngr.com/2017/03/buharis-tenure-may-end-democracy-nigeria-clergy/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer. “The BRCA1 and BRCA2 genes are guardians that look after DNA in our body. “These are really critical genes in every cell of our body and they go through and repair DNA when it gets damaged,’’ Simpson said. He noted that by using a computer programme to map the Genome sequencing of mutations in 560 breast cancers, were able to look at different patterns of mutation and understand how a tumour had arisen. “Results showed that almost 22 per cent of breast tumours had a genetic signature reflecting a BRCA deficiency, even though the patient had not always inherited a mutation in one of the two genes,’’ Simpson said. According to the researcher, in clinical trials at the moment, PARP inhibitor drugs can act to restore these BRCA1 or BRCA2 genes. “It’s very significant; it’s building a really big body of evidence to suggest that in the future we can sequence a patient’s tumour. “We can understand the mutation and say whether the patient will respond better to chemotherapy of the PARP drug. “In the future we can see this kind of test becoming a kind of diagnostic that will determine what type of therapy a patient will have.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer. “The BRCA1 and BRCA2 genes are guardians that look after DNA in our body. “These are really critical genes in every cell of our body and they go through and repair DNA when it gets damaged,’’ Simpson said. He noted that by using a computer programme to map the Genome sequencing of mutations in 560 breast cancers, were able to look at different patterns of mutation and understand how a tumour had arisen. “Results showed that almost 22 per cent of breast tumours had a genetic signature reflecting a BRCA deficiency, even though the patient had not always inherited a mutation in one of the two genes,’’ Simpson said. According to the researcher, in clinical trials at the moment, PARP inhibitor drugs can act to restore these BRCA1 or BRCA2 genes. “It’s very significant; it’s building a really big body of evidence to suggest that in the future we can sequence a patient’s tumour. “We can understand the mutation and say whether the patient will respond better to chemotherapy of the PARP drug. “In the future we can see this kind of test becoming a kind of diagnostic that will determine what type of therapy a patient will have.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer. “The BRCA1 and BRCA2 genes are guardians that look after DNA in our body. “These are really critical genes in every cell of our body and they go through and repair DNA when it gets damaged,’’ Simpson said. He noted that by using a computer programme to map the Genome sequencing of mutations in 560 breast cancers, were able to look at different patterns of mutation and understand how a tumour had arisen. “Results showed that almost 22 per cent of breast tumours had a genetic signature reflecting a BRCA deficiency, even though the patient had not always inherited a mutation in one of the two genes,’’ Simpson said. According to the researcher, in clinical trials at the moment, PARP inhibitor drugs can act to restore these BRCA1 or BRCA2 genes. “It’s very significant; it’s building a really big body of evidence to suggest that in the future we can sequence a patient’s tumour. “We can understand the mutation and say whether the patient will respond better to chemotherapy of the PARP drug. “In the future we can see this kind of test becoming a kind of diagnostic that will determine what type of therapy a patient will have.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research finds more patients suffering from breast cancer could be treated with a drug previously thought to only help those with a genetic gene deficiency. Study researcher Dr. Peter Simpson told Xinhua that when there’s a mutation or deficiency in specific genes, a person can become more susceptible to develop breast cancer.

Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/

Comments

Popular posts from this blog

Soldiers murder pupil, harm others while protecting herdsmen

Senate probes N298m SUV connected to Saraki, Melaye's testament outrage

Herdsmen attacks have turned us to orphans, beggars – Delta Students